+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes



Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes



Obstetrics and Gynecology 130(4): 865-869



To estimate the risk of adverse perinatal outcomes among women with isolated fetal growth restriction from 17 to 22 weeks of gestation. This was a retrospective cohort study of all singleton, nonanomalous pregnancies undergoing ultrasonography to assess fetal anatomy between 17 and 22 weeks of gestation at a single center from 2010 to 2014. After excluding patients with fetal structural malformations, chromosomal abnormalities, or identified infectious etiologies, we compared perinatal outcomes between pregnancies with and without fetal growth restriction, defined as estimated fetal weight less than the 10th percentile for gestational age. Our primary outcome was small for gestational age (SGA) at birth, defined as birth weight less than the 10th percentile. Secondary outcomes included preterm delivery at less than 37 and less than 28 weeks of gestation, preeclampsia, abruption, stillbirth, neonatal death, neonatal intensive care unit admission, intraventricular hemorrhage, need for respiratory support, and necrotizing enterocolitis. Of 12,783 eligible patients, 355 (2.8%) had early second-trimester fetal growth restriction. Risk factors for growth restriction were African American race and tobacco use. Early second-trimester growth restriction was associated with a more than fivefold increase in risk of SGA at birth (36.9% compared with 9.1%, adjusted odds ratio [OR] 5.5, 95% CI 4.3-7.0), stillbirth (2.5% compared with 0.4%, OR 6.2, 95% CI 2.7-12.8), and neonatal death (1.4% compared with 0.3%, OR 5.2, 95% CI 1.6-13.5). Rates of indicated preterm birth at less than 37 weeks of gestation (7.3% compared with 3.3%, OR 2.3, 95% CI 1.5-3.5) and less than 28 weeks of gestation (2.5% compared with 0.2%, OR 10.8, 95% CI 4.5-23.4), neonatal need for respiratory support (16.9% compared with 7.8%, adjusted OR 1.6, 95% CI 1.1-2.2), and necrotizing enterocolitis (1.4% compared with 0.2%, OR 7.7, 95% CI 2.3-20.9) were also significantly higher for those with growth restriction. Rates of preeclampsia, abruption, and other neonatal outcomes were not significantly different. Although fetal growth restriction in the early second trimester occurred in less than 3% of our cohort and most of those with isolated growth restriction did not have adverse outcomes, it is a strong risk factor for SGA, stillbirth, neonatal death, and indicated preterm birth.

(PDF emailed within 0-6 h: $19.90)

Accession: 059639649

Download citation: RISBibTeXText

PMID: 28885423

DOI: 10.1097/AOG.0000000000002209


Related references

Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes. Obstetrics and Gynecology 131(4): 739-740, 2018

Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes. Obstetrics & Gynecology 131(4): 739-740, 2018

Isolated short femur length on second-trimester sonography: a marker for fetal growth restriction and other adverse perinatal outcomes. Journal of Ultrasound in Medicine 31(12): 1935-1941, 2013

Comparative efficiency of measures of early fetal growth restriction for predicting adverse perinatal outcomes. Obstetrics and Gynecology 117(6): 1331-1340, 2011

Relationship between abnormal fetal testing and adverse perinatal outcomes in intrauterine growth restriction. American Journal of Obstetrics and Gynecology 196(5): E48-E51, 2007

Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound in Obstetrics and Gynecology 42(4): 400-408, 2014

Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology 52(4): 430-441, 2018

A Cut-off Value for Gestational Week at Birth for Better Perinatal Outcomes in Early- and Late-Onset Fetal Growth Restriction. Zeitschrift für Geburtshilfe und Neonatologie 2019, 2019

Modified myocardial performance index and its prognostic significance for adverse perinatal outcome in early and late onset fetal growth restriction. Journal of Maternal-Fetal and Neonatal Medicine 2018: 1-6, 2018

Fetal Nasal Bone Length as a Novel Marker for Prediction of Adverse Perinatal Outcomes in the First-Trimester of Pregnancy. Balkan Medical Journal 34(2): 127-131, 2018

Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction. Hypertension in Pregnancy 36(3): 269-275, 2017

Ultrasound measurement of fetal adrenal gland in fetuses with intrauterine growth restriction, an early predictive method for adverse outcomes. Journal of Maternal-Fetal and Neonatal Medicine 2017: 1-7, 2017

Does early second-trimester sonography predict adverse perinatal outcomes in monochorionic diamniotic twin pregnancies?. Journal of Ultrasound in Medicine 33(9): 1573-1578, 2015

Isolated low-normal amniotic fluid volume in the early third trimester: association with adverse perinatal outcomes. Journal of Perinatal Medicine 41(4): 349-353, 2014

Early onset, severe fetal growth restriction with absent or reversed end-diastolic flow velocity waveform in the umbilical artery: perinatal and long-term outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology 49(1): 45-51, 2009